[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339550-105":59,"doc-detail-339550-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","an-integrated-single-cell-rna-seq-map-of-human-neuroblastoma-tumors-and-preclinical-models-uncovers-divergent-mesenchymal-like-gene-expression-programs","An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs","","Neuroblastoma, a common pediatric cancer, shows poor clinical outcomes despite preclinical evidence that mesenchymal-like gene programs may drive chemotherapy resistance. This study builds integrated single-cell RNA-seq maps across neuroblastoma cell lines, patient-derived xenografts, and a genetically engineered mouse model. An unsupervised acNMF approach aligns preclinical programs with patient tumor cohorts, revealing a weak mesenchymal-like signature that persists across models and can be induced rapidly by therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-integrated-single-cell-rna-seq-map-of-human-neuroblastoma-tumors-and-preclinical-models-uncovers-divergent-mesenchymal-like-gene-expression-programs/339550/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-integrated-single-cell-rna-seq-map-of-human-neuroblastoma-tumors-and-preclinical-models-uncovers-divergent-mesenchymal-like-gene-expression-programs/339550.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about neuroblastoma and chemotherapy resistance?","Question",{"text":112,"@type":113},"It examines how patient tumor heterogeneity relates to preclinical models, especially regarding the role of mesenchymal-like gene expression programs in therapy resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets are integrated in the single-cell RNA-seq maps?",{"text":117,"@type":113},"Single-cell RNA-seq maps are generated for neuroblastoma cell lines, patient-derived xenograft (PDX) models, and a genetically engineered mouse model (GEMM).",{"name":119,"@type":110,"acceptedAnswer":120},"How does the study compare gene expression programs across preclinical models and patient tumors?",{"text":121,"@type":113},"It introduces an unsupervised machine learning method, acNMF, to compare preclinical gene expression programs to a large cohort of patient tumor data.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339550,1790528274,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Chapple et al. Genome Biology (2024) 25:161 [https://doi.org/10.1186/s13059-024-03309-4](https://doi.org/10.1186/s13059-024-03309-4)  \nGenome Biology  \nRESEARCH Open Access  \nAn integrated single-cell RNA-seq map  \nof human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs  \nRichard H. Chapple 1, Xueying Liu 1, Sivaraman Natarajan 1, Margaret I. M. Alexander 1, Yuna Kim 1,  \nAnand G. Patel2,3, Christy W. LaFlamme4,5, Min Pan1, William C. Wright 1, Hyeong‑Min Lee 1, Yinwen Zhang1, Meifen Lu6, Selene C. Koo6, Courtney Long7, John Harper7, Chandra Savage7, Melissa D. Johnson8, Thomas Confer8, Walter J. Akers9, Michael A. Dyer2,10, Heather Sheppard6, John Easton 1 and Paul Geeleher1,3*  \n*Correspondence: [paul.geeleher@stjude.org](paul.geeleher@stjude.org)  \n1 Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA  \nFull list of author information is available at the end of the article  \nAbstract  \nBackground: Neuroblastoma is a common pediatric cancer, where preclinical studies suggest that a mesenchymal‑like gene expression program contributes to chemo‑ therapy resistance. However, clinical outcomes remain poor, implying we need a better understanding of the relationship between patient tumor heterogeneity and preclini‑ cal models.  \nResults: Here, we generate single‑cell RNA‑seq maps of neuroblastoma cell lines, patient‑derived xenograft models (PDX), and a genetically engineered mouse model (GEMM) . We develop an unsupervised machine learning approach (“automatic con‑ sensus nonnegative matrix factorization”(acNMF)) to compare the gene expression programs found in preclinical models to a large cohort of patient tumors. We confirm a weakly expressed, mesenchymal‑like program in otherwise adrenergic cancer cells in some pre‑treated high‑risk patient tumors, but this appears distinct from the pre‑ sumptive drug‑resistance mesenchymal programs evident in cell lines. Surprisingly, however, this weak‑mesenchymal‑like program is maintained in PDX and could be chemotherapy‑induced in our GEMM after only 24 h, suggesting an uncharacterized therapy‑escape mechanism.  \nConclusions: Collectively, our findings improve the understanding of how neuroblas‑ toma patient tumor heterogeneity is reflected in preclinical models, provides a com‑ prehensive integrated resource, and a generalizable set of computational methodolo‑ gies for the joint analysis of clinical and pre‑clinical single‑cell RNA‑seq datasets.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the mate‑ rial. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/licenses/by/4.0/](creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publi)[. The Creative Commons Public Domain Dedication waiver (](creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publi)[http://creativecommons.org/publi](creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publi)[cdomain/zero/1](cdomain/zero/1).0/) applies to the data made available in this article, unless ","cbCaigfkPqxpJ2Eq","https://ap.wps.com/l/cbCaigfkPqxpJ2Eq","pdf",6839928,26,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Background","[{\"question\":\"What question does the study address about neuroblastoma and chemotherapy resistance?\",\"answer\":\"It examines how patient tumor heterogeneity relates to preclinical models, especially regarding the role of mesenchymal-like gene expression programs in therapy resistance.\"},{\"question\":\"Which datasets are integrated in the single-cell RNA-seq maps?\",\"answer\":\"Single-cell RNA-seq maps are generated for neuroblastoma cell lines, patient-derived xenograft (PDX) models, and a genetically engineered mouse model (GEMM).\"},{\"question\":\"How does the study compare gene expression programs across preclinical models and patient tumors?\",\"answer\":\"It introduces an unsupervised machine learning method, acNMF, to compare preclinical gene expression programs to a large cohort of patient tumor data.\"}]","An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs | PDF",1790030991,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8c4d25bb973cd8493643ab2f022e02e.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6af8374be051ff6434226b189e021d57.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46b4e018782044821e9942473595e516.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a1f8d51d1b269b88e0ec0be69dc059a.webp",980,1301]